 |
answer text |
<p>The Medical Research Council (MRC) covers basic through to translational research,
with translational research and applied, clinical, public health and social care research
funded by the Department via the National Institute for Health Research (NIHR).</p><p>The
NIHR’s funding for research includes support for research infrastructure which is
critically important in providing the resources, support and facilities that the National
Health Service needs to conduct first-class research across the full pathway of discovery
science to evaluation. The sustained, long-term funding to put in place through the
NIHR infrastructure has been widely recognised as having transformed the health research
environment in the United Kingdom. For example, there has been five-fold increase
in early phase (phase I and phase II) trials since 2009 within the NIHR early translational
research infrastructure in the NHS (2,842 phase I and phase II trials in 2017/18 compared
to just 496 in 2009/10).</p><p>The MRC are also currently undertaking an evaluation
of 10 years of MRC-funded translation research which is expected to be completed in
September 2019.</p><p>The MRC and the NIHR also work in partnership through the Efficacy
and Mechanism Evaluation programme which funds studies evaluating interventions with
potential to make a step-change in the promotion of health, treatment of disease and
improvement of rehabilitation or long-term care.</p><p> </p><p><strong> </strong></p><p><strong>
</strong></p>
|
|
